Product Information
DIVALPROEX SOD DR 250 MG TAB is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0856 per EA under NDC 57237004705. Its NADAC has been published 650 times since Apr 9, 2014.
FDA first approved this application on Apr 21, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237004705
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DIVALPROEX SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA090554FDA Approved
4/21/2011
TE Code
AB
On Market Since
10/24/2014
Pharmacological Classes
Price Statistics
The NADAC for DIVALPROEX SOD DR 250 MG TAB has been published 650 times since Apr 9, 2014, and over the history we have for it it has risen 6.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0856 per EA |
|---|---|
| All-time high | $0.1904 (Sep 10, 2014) |
| All-time low | $0.0676 (Apr 17, 2019) |
| 52-week high | $0.0959 |
| 52-week low | $0.0851 |
| Median price | $0.0858 |
| Average price | $0.0913 |
| Largest weekly change | +146.5% (Aug 20, 2014) |
| Weeks tracked | 650 |
| Tracking since | Apr 9, 2014 |
Generic Alternatives
The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Divalproex Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anti-epileptic Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DIVALPROEX SOD DR 250 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DIVALPROEX SOD DR 250 MG TAB, manufactured by Rising Pharma Holdings Inc., is $0.0856 per EA (NDC 57237004705), effective Sep 30, 2026.
How has the price of DIVALPROEX SOD DR 250 MG TAB changed over time?
Over the history we have for it, the NADAC for DIVALPROEX SOD DR 250 MG TAB has risen 6.7%. It has been tracked across 650 weekly CMS publications since Apr 9, 2014.
What are the highest and lowest recorded NADAC prices for DIVALPROEX SOD DR 250 MG TAB?
Since Apr 9, 2014, the NADAC for DIVALPROEX SOD DR 250 MG TAB has ranged from a low of $0.0676 (Apr 17, 2019) to a high of $0.1904 (Sep 10, 2014), with a median of $0.0858 per EA.
Are there cheaper alternatives to DIVALPROEX SOD DR 250 MG TAB?
Yes. 12 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DIVALPROEX SOD DR 250 MG TAB, is $0.0833 per EA — about 3% below DIVALPROEX SOD DR 250 MG TAB.
Who manufactures DIVALPROEX SOD DR 250 MG TAB?
DIVALPROEX SOD DR 250 MG TAB (NDC 57237004705) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.